Aurobindo Pharma reported INR51.23B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Cipla INR 39.1B 2.54B Mar/2026
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Dr.Reddys Laboratories INR 37.77B 13.6B Mar/2026
Hindustan Unilever INR 78.72B 2.41B Mar/2026
Sun Pharmaceuticals INR 125.24B 17.58B Dec/2025
UPL INR 55.96B 1.01B Dec/2025